Mental Health Patients at High Risk for Obesity, Type 2 Diabetes, and Cardiovascular Disease: An Australian Perspective

被引:0
|
作者
Stanley, Susanne H. [1 ]
Laugharne, Jonathan D. E. [1 ]
机构
[1] Univ Western Australia, Fremantle Hosp, Sch Psychiat & Clin Neurosci, Community Culture & Mental Hlth Unit, W Block,L6,1 Alma St, Fremantle, WA 6160, Australia
关键词
Mental illness; obesity; type; 2; diabetes; cardiovascular disease;
D O I
10.2174/1573402111107030160
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In Australia, rates of obesity in the general population are on the rise. The growing incidence of obesity and higher rates of metabolic syndrome in mental health patients places this group of people at a much higher risk for type 2 diabetes and cardiovascular disease. Treatment effects via psychotropic medications, and lifestyle factors such as diet and exercise suggests that attention needs to be drawn to this vulnerable population. Assessment and the ongoing monitoring of physical health is essential in the prevention of major physical illness in people with a mental disorder.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 50 条
  • [41] Targeting abdominal obesity to reduce cardiovascular risk in patients with type 2 diabetes mellitus - Introduction
    Aronne, Louis J.
    AMERICAN JOURNAL OF MEDICINE, 2007, 120 (2A): : S1 - S2
  • [42] Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older Adults The Cardiovascular Health Study
    Jensen, Majken K.
    Bartz, Traci M.
    Mukamal, Kenneth J.
    Djousse, Luc
    Kizer, Jorge R.
    Tracy, Russell P.
    Zieman, Susan J.
    Rimm, Eric B.
    Siscovick, David S.
    Shlipak, Michael
    Ix, Joachim H.
    DIABETES CARE, 2013, 36 (05) : 1222 - 1228
  • [43] Obesity Genotype Score and Cardiovascular Risk in Women With Type 2 Diabetes
    He, Meian
    Cornelis, Marilyn C.
    Franks, Paul W.
    Zhang, Cuilin
    Hu, Frank B.
    Qi, Lu
    CIRCULATION, 2009, 120 (18) : S467 - S467
  • [44] Obesity and cardiovascular risk factors in patients with type 2 diabetes:: data from the Swedish National Diabetes Register
    Ridderstråle, M
    Cederholm, J
    Eliasson, B
    Nilsson, PM
    Gudbjörnsdottir, S
    DIABETOLOGIA, 2005, 48 : A260 - A260
  • [45] Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
    Toth, Peter P.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 9 - 23
  • [46] Incident cardiovascular disease in patients with type 2 diabetes: Established cardiovascular disease versus traditional risk markers
    Jensen, J.
    Schou, M.
    Kistorp, C.
    Faber, J.
    Hansen, T. W.
    Jensen, M. T.
    Andersen, H. U.
    Rossing, P.
    Vilsboll, T.
    Jorgensen, P. G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2677 - 2677
  • [47] Cardiovascular risk stratification in patients with type 2 diabetes
    Htoo, Phyo Than T.
    Wexler, Deborah
    Glynn, Robert J.
    Schneeweiss, Sebastian
    Paik, Julie M.
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 308 - 309
  • [48] Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes
    Motairek, Issam
    Al-Kindi, Sadeer
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 135 - 147
  • [49] Cardiovascular risk stratification in patients with type 2 diabetes
    Grossmann, V.
    Schmitt, V. H.
    Juenger, C.
    Muenzel, T.
    Wild, P. S.
    DIABETOLOGE, 2014, 10 (07): : 572 - 580
  • [50] Estimation of Cardiovascular Risk in Patients with Type 2 Diabetes
    Vicente Sanchez, Belkis
    Vicente Pena, Ernesto
    Costa Cruz, Miriam
    FINLAY, 2015, 5 (03): : 178 - 188